Form4insider filings, from the source

SEC Form 4 · accession 0001708138-17-000010

REGENERON PHARMACEUTICALS, INC. · REGN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Neil Stahl
Officer — EVP Research and Development
Period of report
Jun 21, 2017
Accepted (ET)
Jun 23, 2017 · 4:09 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJun 21, 2017M20,000$30.63A43,950D
Common StockJun 21, 2017F1,201$510.02D42,749D
Common StockJun 21, 2017F10,493$510.02D32,256D
Common StockJun 22, 2017S100$521.70D32,156D
Common StockF2Jun 22, 2017S200$522.80D31,956D
Common StockF3Jun 22, 2017S200$523.52D31,756D
Common StockJun 22, 2017S101$524.08D31,655D
Common StockF4Jun 22, 2017S400$525.10D31,255D
Common StockF5Jun 22, 2017S600$526.45D30,655D
Common StockJun 22, 2017S100$529.61D30,555D
Common StockF6Jun 22, 2017S800$530.64D29,755D
Common StockF7Jun 22, 2017S900$531.42D28,855D
Common StockF8Jun 22, 2017S500$532.44D28,355D
Common StockF9Jun 22, 2017S905$533.49D27,450D
Common StockF10Jun 22, 2017S700$534.64D26,750D
Common StockF11Jun 22, 2017S800$535.37D25,950D
Common StockF12Jun 22, 2017S800$536.46D25,150D
Common StockF13Jun 22, 2017S200$537.42D24,950D
Common StockF14Jun 22, 2017S600$538.39D24,350D
Common StockF15Jun 22, 2017S200$539.36D24,150D
Common StockJun 22, 2017S100$540.04D24,050D
Common StockJun 22, 2017S100$541.70D23,950D
Common Stockholding———10,000Iby GRAT
Common Stockholding———5,000Iby GRAT
Common Stockholding———5,647IBy 401(k) Plan

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Non-Qualified Stock Option (right to buy)F16$30.63Jun 21, 2017M20,000D—Dec 14, 2020Common Stock20,00026,736D

Explanation of responses